Abstract

Atrial fibrillation following high-dose i.v. steroids for treatment of severe immune-mediated diseases has been rarely reported in the literature. Here we report a further case of atrial fibrillation following high-dose i.v. methylprednisolone (HDIVMP) therapy of severe thrombocytopenia in a female patient with a flare-up of systemic lupus erythematosus (SLE). The available literature on this topic is reviewed as well.

Cite this article as: Romano C, Sirotti V, Farinaro V, Luiso V, Solaro E, De Sio C, et al. Atrial fibrillation following therapy with high-dose i.v. methylprednisolone: A brief case-based review. Eur J Rheumatol 2017; 4: 231-3.